Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 13 of 18
Newsletters
The CEO’s Job Is Tougher Than Ever
By
Aaron Pressman
and
Adam Lashinsky
November 18, 2019
Finance
What the Sackler Offer and the J&J Opioid Verdict Tell Us About the Next Big Test for Drugmakers—an Ohio Trial in October
By
Research Team
August 27, 2019
Health
J&J Shares Rise After Lower Than Expected Award for Company’s Part in Opioid Crisis
By
Jef Feeley
,
Riley Griffin
and
Bloomberg
August 27, 2019
Johnson & Johnson Accused of Dodging Liability for Its Alleged Role in Opioid Epidemic
By
Jef Feeley
and
Bloomberg
July 15, 2019
Health
Johnson & Johnson to Test a Pioneering HIV Vaccine: Brainstorm Health
By
News Correspondent
July 12, 2019
Leadership
J&J CEO’s West Point Lesson: Great Leaders Know How to Listen
By
Financial Writer
April 17, 2019
Xarelto to Become First Prescription Drug With TV Ads That Includes Pricing
By
Investment Desk
March 29, 2019
Jury Awards $29 Million in Latest Johnson & Johnson Cancer-Causing Baby Powder Lawsuit
By
Editorial Team
March 15, 2019
Finance
Mithril Capital’s Ajay Royan Talks About Working with Peter Thiel and Why ‘Investing Is Hard’
By
Research Team
February 28, 2019
Johnson & Johnson Will Be The First Drug Company To Put Prescription Medication Prices in TV Ads
By
Industry Analyst
February 8, 2019
Johnson & Johnson’s Slowdown Signals a Warning to Health Care Sector
By
Financial Writer
January 22, 2019
Health
Johnson & Johnson’s $50 Billion Baby Powder Problem Just Got a Whole Lot Worse. Here’s Why
By
News Correspondent
December 19, 2018
Glaxo to Split in Two Following Venture Deal with Pfizer
By
Crypto Correspondent
December 19, 2018
Leadership
Companies Strike Back, Moonves Fired, China: CEO Daily for December 18, 2018
By
Lucas Laursen
and
Alan Murray
December 18, 2018
Health
Johnson & Johnson Knew Baby Powder Contained Asbestos for Decades, Report Claims
By
Blockchain Reporter
December 14, 2018
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Senior Editor
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Financial Writer
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Digital Assets Editor